Pharmacogenomics Implementation at the National Institutes of Health Clinical Center
Tristan M. Sissung(National Institutes of Health), Barry R. Goldspiel(National Institutes of Health Clinical Center), Jharana Patel(National Institutes of Health Clinical Center), Frank Mickey(National Institutes of Health Clinical Center), Ryan N. Baugher(Leidos (United States)), Jon W McKeeby(National Institutes of Health Clinical Center), Mary E. Barcus, Gary DiPatrizio(National Institutes of Health Clinical Center), Parag Kumar(National Institutes of Health Clinical Center), Kristen Pike(Science Applications International Corporation (United States)), Teri M. Plona(Leidos (United States)), William D. Figg(National Cancer Institute), Ellen J. Eckes(Surgical Specialties (United States)), Juan J.L. Lertora(National Institutes of Health Clinical Center), Sharon Adams(National Institutes of Health Clinical Center), Xiaolin Wu(Leidos (United States)), Daniel Soppet(Leidos (United States)), Willy A. Flegel(National Institutes of Health Clinical Center), Vivekananda Datta(Leidos (United States)), Stephanie D. Mellott(Leidos (United States))
Cited by 24
Related Papers
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
|New England Journal of Medicine|2010|560
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
|Journal of Clinical Investigation|2018|519
Molecular Basis of Weak D Phenotypes
|Blood|1999|336
Molecular Basis of Weak D Phenotypes
|Blood|1999|331